Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Heart. 2016 Feb;102(3):204-8. doi: 10.1136/heartjnl-2015-308429. Epub 2015 Dec 23.
Minimal data are available regarding the long-term mortality risk of subclinical atherosclerosis using coronary artery calcium (CAC) scoring among patients with a family history (FH) of coronary artery disease (CAD). The aim of the present analysis was to assess the prognostic utility of CAC scoring among cohorts of young and older patients with and without a FH of CAD.
A total of 9715 consecutive asymptomatic patients, free of known CAD, underwent CAC scoring for cardiovascular risk assessment. The primary end point was all-cause mortality, with a median follow-up of 14.6 years. Unadjusted and risk-factor adjusted Cox proportional hazard modelling was employed. We calculated the area under the curve (AUC) from receiver operating characteristics analysis.
15-year all-cause mortality rates ranged from 4.7% to 25.0% for FH patients and from 5.0% to 38.0% for non-FH patients with CAC scores of 0 to >400 (p<0.0001). Effect modification by age altered the mortality risk of CAC among FH patients. For patients aged >60 years with FH of CAD, there was a significant improvement in the AUC with CAC over CAD risk factors (AUC: 0.539 vs 0.725, p<0.001). No such improvement was observed in FH patients aged <60 years (AUC: 0.636 vs 0.626, p=0.67).
CAC effectively stratified mortality risk of patients with and without FH of CAD. However, for younger and lower-risk FH cohorts, CAC screening did not provide additive prognostic information beyond that of the traditional cardiac risk factors.
在有冠心病家族史(FH)的患者中,使用冠状动脉钙评分(CAC)对亚临床动脉粥样硬化的长期死亡率风险的数据有限。本分析的目的是评估 CAC 评分在有和没有 FH 的年轻和老年患者队列中的预后价值。
共有 9715 例连续的无症状患者,无已知的 CAD,接受 CAC 评分进行心血管风险评估。主要终点是全因死亡率,中位随访时间为 14.6 年。采用未调整和风险因素调整的 Cox 比例风险模型进行分析。我们从接受者操作特征分析中计算曲线下面积(AUC)。
FH 患者的 CAC 评分为 0 至>400 的 15 年全因死亡率从 4.7%至 25.0%不等,非 FH 患者的 15 年全因死亡率从 5.0%至 38.0%不等(p<0.0001)。年龄的效应修饰改变了 FH 患者 CAC 的死亡率风险。对于年龄>60 岁且有 FH 的 CAD 患者,CAC 在 CAD 危险因素方面的 AUC 显著提高(AUC:0.539 与 0.725,p<0.001)。在年龄<60 岁的 FH 患者中未观察到这种改善(AUC:0.636 与 0.626,p=0.67)。
CAC 有效地对有和没有 FH 的 CAD 患者的死亡率风险进行分层。然而,对于年轻和低风险的 FH 队列,CAC 筛查除了传统的心脏危险因素之外,并没有提供额外的预后信息。